IN PERSON GM Highlight: Leadership Insights in the Pharmaceutical Industry

Speakers

• 

  Frank Fascinato President & Founder, Treviso Consulting
  

  Frank Fascinato

  President & Founder, Treviso Consulting

  Leveraging over 20 years in the pharma sector, across sales, training, marketing, commercial operations, and senior leadership, Frank now leads operations as President and Founder of Treviso Consulting – a pharma-focused firm specializing in personalized career coaching for top talent pharmaceutical professionals and business consulting services for individuals and teams looking to solve complex business challenges.

  Frank is known for his engaging leadership, inspiring others to grow, and driving performance through bold innovation. Leveraging insights, data, and harnessing technology, he’s an agent for change, able to challenge people and organizations to think differently and win big!

  Inspired by the purpose of the OPMA, Frank brings his experience and strategic thinking to the team to continue the impactful work of the association in connecting pharmaceutical professionals to grow their networks and develop in their careers.

• 

  Karen Heim VP & General Manager, Alexion Canada
  

  Karen Heim

  VP & General Manager, Alexion Canada

  Global Executive | 20+ years of leadership in Business Units, Brands & Government Affairs | Market Access
  I’ve had the privilege of leading large Business Units and Global Brands throughout an exciting 20-plus years in health care – spanning Canada, Nordics and the U.S., as well as marketing, market access and government affairs, and sales functions.

  My professional journey has been about unlocking the power of science for the benefit of patients, delivering top tier performance, and bringing creative thinking to every new opportunity and challenge in what is an incredibly dynamic health care environment. It’s also about working with great people and embracing the opportunity to grow and stretch myself. I believe in nurturing talent, fostering inclusivity, and creating cultures where innovation thrives.

  Over the past decade I’ve had the opportunity to deliver innovative, life-changing medicines and solutions for millions of people affected by the complex spectrum of cardiovascular, renal and metabolism (CVRM) diseases with our strong and expanding portfolio and one of the broadest, deepest, most innovative pipelines in the industry.

  Highlights:
  Multi-faceted leadership roles in marketing, sales, market access, and government relations. Active proponent of talent development & champion of inclusive cultures. I am an Engineer at heart, and a strategist in execution.

  Here’s to a world where we innovate each day to advance patient care and inclusively grow together

• 

  Michael Stone Country Manager for Canada, Merz Therapeutics
  

  Michael Stone

  Country Manager for Canada, Merz Therapeutics

  I am a pharmaceutical and medical device leader. I have held roles in executive leadership in large pharma and general management in small biopharma. I have critically evaluated growth opportunities and have championed break through launches. My therapeutic span is diverse having grown innovative brands in broad primary care through to rare disease with experience in neurology, immunology, hematology, critical care, oncology, osteoporosis, men’s health, psychiatry, chronic pain, women’s health, cardiology and diabetes.
  I have developed and guided complex patient support programming across therapeutic areas to deliver exceptional patient and HCP experiences and support early and sustained brand uptake.

  As an authentic and inclusive leader, I have built diverse large and small teams that exceed expectations. I have also restructured and transformed teams and culture to succeed in new therapeutic areas.

  I am energized by marketing challenges. I was recently inducted in to the Canadian Pharmaceutical Marketing Hall of Fame. My teams have been successful starting with deep understanding of the insights beneath the customer behavior. I do not believe “if you build it, they will come”, I begin with “why”, not “what”.

• 

  Robin Hunter Industry General Manager
  

  Robin Hunter

  Industry General Manager
• 

  Tamara Seales-Knights President, Seaford Pharmaceuticals
  

  Tamara Seales-Knights

  President, Seaford Pharmaceuticals

  Tamara Seales-Knights is the President of Seaford Pharmaceuticals, where she has been a cornerstone of the company’s growth for 25+ years. As President, She oversees administration, finance, strategy, and marketing, and has played a pivotal role in expanding Seaford’s reach. Her leadership includes strengthening the company’s commercialization acumen and building strategic partnerships with key stakeholders, including the Federal Economic Development Agency and the National Research Council.

  A graduate of York University (B.Comm) and the Schulich School of Business (MBA), Tamara combines strong business expertise with a commitment to industry collaboration and community impact. She serves on the Board of Governors at FHCP (Food, Health, and Consumer Products Canada), as well as its Health Product Committee and Membership Committee. She is also an advisory board member with Brampton Venture Zone at Toronto Metropolitan University, an active member of Life Sciences Ontario, and a frequent speaker and panelist at a number of industry associations and events, including the Mississauga Board of Trade and the National Pharmaceutical Congress.

  Beyond her professional contributions, Tamara leads Seaford’s charitable initiatives, including the establishment of a pediatric clinic in Jamaica, disaster relief efforts, and fundraising in support of women’s health and cancer research. Her vision continues to drive progress across the pharmaceutical sector while making a lasting impact in the community.